
About Orcas Pharmaceuticals Private Limited
Data last updated:
Orcas Pharmaceuticals Private Limited is a private limited company based in Pennagaram, Tamil Nadu, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 06 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U52311TZ2012PTC018721. Its GSTIN is 33AABCO7171J1ZD (Tamil Nadu).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹36.9 Lakh. It is led by directors including Manivel Elaiyabharathi and Kannan Shanmugam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pennagaram, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.08 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹4.99 Lakh (net margin 1.2%) and EBITDA of ₹8.32 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 16% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹80 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orcaspharma.in.
Company details
Contact details
Orcas Pharmaceuticals Private Limited's registered office is in Pennagaram, Tamil Nadu. Its website is orcaspharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSurvey No.377/5 Kadagathur X Road, Kadagathur Post, Pennagaram, Tamil Nadu, India – 636809
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Orcas Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Orcas Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Orcas Pharmaceuticals Private Limited, buy the company report.
Financials of Orcas Pharmaceuticals Private Limited
FY 2025 filings availableOrcas Pharmaceuticals Private Limited reported revenue of ₹4.08 Cr (up 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 19% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orcas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Orcas Pharmaceuticals Private Limited
Orcas Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manivel Elaiyabharathi | Director | 27 Apr 2023 | 3 Years 6 Months | Current |
| Kannan Shanmugam | Director | 06 Sep 2012 | 14 Years 2 Months | Current |
| Ranjana Devi Muniyappan | Director | 10 Feb 2025 | 1 Years 9 Months | Current |
Peer comparison
Orcas Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zaneka Pharmaceuticals Private Limited | ₹4.17 Cr (FY 2025) | -3.0% | Haridwar, Uttarakhand, India | |||
| MSR Pharmaceuticals Private Limited | ₹4.11 Cr (FY 2025) | -10.0% | Patna, Bihar, India | |||
| Orcas Pharmaceuticals Private Limitedthis company | ₹4.08 Cr (FY 2024) | ₹4.99 Lakh | 1.2% | 19.0% | 9 | Pennagaram, Tamil Nadu, India |
| Tabilac Pharmaceuticals Private Limited | ₹4.06 Cr (FY 2024) | 1213.0% | Sonipat, Haryana, India |
To see the full peer comparison of Orcas Pharmaceuticals Private Limited, buy the company report.
Auditor
Orcas Pharmaceuticals Private Limited is audited by KUMARESAN & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMARESAN & CO | FY 2021 | 006068S |
Shareholding
The shareholding of Orcas Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Orcas Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Apr 2025 | 101118084 | Axis Bank Limited | ₹80 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Orcas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orcas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Orcas Pharmaceuticals Private Limited has a workforce of 9 employees on its EPFO records as of Oct 2023, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2023-24 | 9 |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2019-20 | |
| FY 2018-19 |
To see the full employee and EPFO history of Orcas Pharmaceuticals Private Limited, buy the company report.
GST
Orcas Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCO7171J1ZD | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Orcas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Orcas Pharmaceuticals Private Limited has 5 board changes on record since 2012: 3 appointments and 2 cessations. The latest: Ranjana Devi Muniyappan was appointed as Director on 10 Feb 2025.
Frequently asked questions
Orcas Pharmaceuticals is an active private limited company based in Pennagaram, Tamil Nadu, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 06 September 2012 (14+ years old) and is registered under CIN U52311TZ2012PTC018721.
Orcas Pharmaceuticals has 3 current directors:
- Manivel Elaiyabharathi - Director
- Kannan Shanmugam - Director
- Ranjana Devi Muniyappan - Director
The latest financial statements of Orcas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Orcas Pharmaceuticals is 33AABCO7171J1ZD, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Orcas Pharmaceuticals is U52311TZ2012PTC018721. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orcas Pharmaceuticals was incorporated on 06 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Orcas Pharmaceuticals by revenue are Zaneka Pharmaceuticals Private Limited, MSR Pharmaceuticals Private Limited, Tabilac Pharmaceuticals Private Limited, all in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ranjana Devi Muniyappan was appointed as Director on 10 Feb 2025. Manivel Elaiyabharathi ceased to be Additional Director on 29 Sep 2023. Sudarvannan Manivel ceased to be Managing Director on 09 Jun 2023. Orcas Pharmaceuticals has 5 board changes on record in total.
Orcas Pharmaceuticals can be reached through the website orcaspharma.in. Its registered office is in Pennagaram, Tamil Nadu, India.
The registered office of Orcas Pharmaceuticals is at Survey No.3775 Kadagathur X Road, Kadagathur Post, Pennagaram, Tamil Nadu, India – 636809.
Orcas Pharmaceuticals operates in the pharma industry, in the animal pharmaceuticals and healthcare segment.

